We are live on ! Find out more
AI

Axiom Investors Portfolio holdings

AUM $8.99B
1-Year Est. Return 44.68%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+44.68%
3 Year Est. Return
+214.21%
5 Year Est. Return
+302.8%
10 Year Est. Return
+1,834.44%
AUM
$3.99B
AUM Growth
-$465M
Cap. Flow
-$680M
Cap. Flow %
-17.06%
Top 10 Hldgs %
41.63%
Holding
165
New
26
Increased
36
Reduced
76
Closed
25

Top Buys

Rank Stock Value
1
NTES icon
NetEase
NTES
+$53.5M
2
AMX icon
America Movil
AMX
+$35.8M
3
BIIB icon
Biogen
BIIB
+$27.4M
4
STZ icon
Constellation Brands
STZ
+$25.9M
5
ZTS icon
Zoetis
ZTS
+$22.5M

Top Sells

Rank Stock Value
1
INDA icon
iShares MSCI India ETF
INDA
+$56.3M
2
JD icon
JD.com
JD
+$50.6M
3
TCOM icon
Trip.com Group
TCOM
+$49.9M
4
BKNG icon
Booking.com
BKNG
+$42.6M
5
CX icon
Cemex
CX
+$39.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.94%
2 Financials 19.39%
3 Technology 18.97%
4 Communication Services 13.34%
5 Industrials 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLAY icon
151
Dave & Buster's
PLAY
$364M
-5,030
Closed -$264K
ROL icon
152
Rollins
ROL
$18.1B
-705,105
Closed -$14.5M
TCMD icon
153
Tactile Systems Technology
TCMD
$676M
-113,484
Closed -$3.51M
TLK icon
154
Telkom Indonesia
TLK
$14.6B
-423,820
Closed -$14.5M
ULTA icon
155
Ulta Beauty
ULTA
$23.2B
-101,395
Closed -$22.9M
VCYT icon
156
Veracyte
VCYT
$3.71B
-388,328
Closed -$3.41M
VNDA icon
157
Vanda Pharmaceuticals
VNDA
$306M
-137,167
Closed -$2.46M
NVRO
158
DELISTED
NEVRO CORP.
NVRO
-33,464
Closed -$3.04M
PRTK
159
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-49,752
Closed -$1.25M
FRC
160
DELISTED
First Republic Bank
FRC
-199,320
Closed -$20.8M
TTM
161
DELISTED
Tata Motors Limited
TTM
-18,800
Closed -$588K
MNDT
162
DELISTED
Mandiant, Inc. Common Stock
MNDT
-172,371
Closed -$2.89M
AGN
163
DELISTED
Allergan plc
AGN
-154,600
Closed -$31.7M
SGYP
164
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
-760,518
Closed -$2.21M
MSCC
165
DELISTED
Microsemi Corp
MSCC
-42,953
Closed -$2.21M

Similar funds

Axiom Investors's Q4 2017 Portfolio in Review

As of Q4 2017, Axiom Investors held 165 positions worth $3.99B, down 10% from $4.45B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Axiom Investors withdrew a net $680M in Q4 2017, closing 25 positions and reducing 76 holdings. Its most notable exit was Cemex, an estimated $39.7M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, down from 25% a quarter earlier, followed by Financials and Technology.

Against the trend, Axiom Investors opened a new position in Biogen worth $27.2M.

  • Axiom Investors's largest Q4 2017 buy was Biogen: 85,430 shares worth $27.2M.
  • Axiom Investors added most to NetEase in Q4 2017, an estimated $53.5M increase.
  • Axiom Investors's biggest Q4 2017 reduction was iShares MSCI India ETF, cutting an estimated $56.3M.
  • Axiom Investors fully exited Cemex in Q4 2017, selling an estimated $39.7M.
  • Axiom Investors's ten largest holdings make up 42% of its $3.99B portfolio in Q4 2017.
  • Axiom Investors opened 26 new positions and closed 25 in Q4 2017.
  • Axiom Investors's portfolio value fell 10% quarter-over-quarter to $3.99B.

Based on Axiom Investors's 13F filing for Q4 2017, filed 14 Feb 2018.